Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -26.08 Million CNY | -201.58% |
| 2022 | 25.68 Million CNY | -66.29% |
| 2021 | 76.19 Million CNY | -81.61% |
| 2020 | 414.41 Million CNY | 361.32% |
| 2019 | 89.83 Million CNY | -3.44% |
| 2018 | 93.02 Million CNY | 7.69% |
| 2017 | 86.38 Million CNY | 3.7% |
| 2016 | 83.3 Million CNY | 240.85% |
| 2015 | 24.44 Million CNY | -32.89% |
| 2014 | 36.42 Million CNY | 17.19% |
| 2013 | 31.08 Million CNY | -12.99% |
| 2012 | 35.72 Million CNY | 12.68% |
| 2011 | 31.7 Million CNY | -4.13% |
| 2010 | 33.06 Million CNY | 68.25% |
| 2009 | 19.65 Million CNY | 127.19% |
| 2008 | 8.65 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5.26 Million CNY | 95.22% |
| 2024 Q2 | -4.89 Million CNY | 7.05% |
| 2024 Q3 | -5.14 Million CNY | -5.17% |
| 2023 Q4 | -110.13 Million CNY | -1253.49% |
| 2023 Q1 | 36 Million CNY | 226.62% |
| 2023 Q2 | 38.49 Million CNY | 6.93% |
| 2023 FY | -26.08 Million CNY | -201.58% |
| 2023 Q3 | 9.54 Million CNY | -75.2% |
| 2022 FY | 25.68 Million CNY | -66.29% |
| 2022 Q3 | 8.48 Million CNY | 181.79% |
| 2022 Q1 | 16.55 Million CNY | 378.92% |
| 2022 Q2 | -10.37 Million CNY | -162.7% |
| 2022 Q4 | 11.02 Million CNY | 29.85% |
| 2021 Q2 | 34.95 Million CNY | 27.02% |
| 2021 Q1 | 27.51 Million CNY | -23.37% |
| 2021 Q3 | 19.65 Million CNY | -43.75% |
| 2021 Q4 | -5.93 Million CNY | -130.18% |
| 2021 FY | 76.19 Million CNY | -81.61% |
| 2020 FY | 414.41 Million CNY | 361.32% |
| 2020 Q4 | 35.91 Million CNY | -60.11% |
| 2020 Q3 | 90.02 Million CNY | -62.07% |
| 2020 Q2 | 237.32 Million CNY | 363.96% |
| 2020 Q1 | 51.15 Million CNY | 252.3% |
| 2019 Q4 | 14.51 Million CNY | -59.92% |
| 2019 FY | 89.83 Million CNY | -3.44% |
| 2019 Q1 | 20.8 Million CNY | -6.65% |
| 2019 Q2 | 18.28 Million CNY | -12.12% |
| 2019 Q3 | 36.22 Million CNY | 98.14% |
| 2018 Q3 | 23.78 Million CNY | 8.69% |
| 2018 Q2 | 21.88 Million CNY | -12.69% |
| 2018 Q4 | 22.28 Million CNY | -6.32% |
| 2018 FY | 93.02 Million CNY | 7.69% |
| 2018 Q1 | 25.06 Million CNY | 94.65% |
| 2017 Q4 | 12.87 Million CNY | -50.28% |
| 2017 FY | 86.38 Million CNY | 3.7% |
| 2017 Q1 | 22.19 Million CNY | -1.98% |
| 2017 Q3 | 25.9 Million CNY | 1.96% |
| 2017 Q2 | 25.4 Million CNY | 14.45% |
| 2016 Q2 | 17.46 Million CNY | -7.02% |
| 2016 FY | 83.3 Million CNY | 240.85% |
| 2016 Q1 | 18.78 Million CNY | 4525.77% |
| 2016 Q4 | 22.64 Million CNY | -7.2% |
| 2016 Q3 | 24.4 Million CNY | 39.73% |
| 2015 Q2 | -2.64 Million CNY | -136.7% |
| 2015 Q4 | -424.47 Thousand CNY | -102.09% |
| 2015 Q3 | 20.29 Million CNY | 866.9% |
| 2015 FY | 24.44 Million CNY | -32.89% |
| 2015 Q1 | 7.21 Million CNY | -48.48% |
| 2014 Q2 | 7.78 Million CNY | -5.85% |
| 2014 Q3 | 6.37 Million CNY | -18.09% |
| 2014 Q4 | 13.99 Million CNY | 119.63% |
| 2014 FY | 36.42 Million CNY | 17.19% |
| 2014 Q1 | 8.26 Million CNY | 243.03% |
| 2013 Q1 | 6.36 Million CNY | -37.86% |
| 2013 Q3 | 9.76 Million CNY | -22.09% |
| 2013 Q4 | 2.4 Million CNY | -75.33% |
| 2013 FY | 31.08 Million CNY | -12.99% |
| 2013 Q2 | 12.53 Million CNY | 96.96% |
| 2012 Q1 | 4.09 Million CNY | -43.34% |
| 2012 Q4 | 10.24 Million CNY | -9.29% |
| 2012 Q3 | 11.29 Million CNY | 11.94% |
| 2012 FY | 35.72 Million CNY | 12.68% |
| 2012 Q2 | 10.08 Million CNY | 146.37% |
| 2011 Q1 | 2.43 Million CNY | -77.8% |
| 2011 FY | 31.7 Million CNY | -4.13% |
| 2011 Q2 | 17.01 Million CNY | 599.8% |
| 2011 Q4 | 7.22 Million CNY | 43.72% |
| 2011 Q3 | 5.02 Million CNY | -70.44% |
| 2010 Q3 | 7.98 Million CNY | 0.0% |
| 2010 Q4 | 10.95 Million CNY | 37.23% |
| 2010 FY | 33.06 Million CNY | 68.25% |
| 2009 FY | 19.65 Million CNY | 127.19% |
| 2008 FY | 8.65 Million CNY | 0.0% |